首页 | 本学科首页   官方微博 | 高级检索  
     


Bauhinia forficata in the treatment of diabetes mellitus: a patent review
Authors:Bárbara Verônica Cardoso de Souza  Regilda Saraiva dos Reis Moreira Araújo  Oskar Almeida Silva  Lucas Costa Faustino  Maria Fabrícia Beserra Gonçalves  Mirian Lima Dos Santos
Affiliation:1. Nutrition Department, Federal University of Piauí, Piauí, Brazil;2. Postgraduate Program of Biotechnology, Federal University of Piauí, Piauí, Brazil;3. Department of Chemistry, Federal University of Piauí, Piauí, Brazil;4. Department of Pharmacy, Federal University of Piauí, Piauí, Brazil
Abstract:Introduction: Diabetes Mellitus has been considered an epidemic by the World Health Organization, with a high risk of morbidity and mortality. The treatment of this pathology consists in glycemic control, which can be done by oral hypoglycemic agents, insulin therapy, dietary guidance, regular physical activity, and psychosocial support. In addition, other adjuvant treatments are employed, such as phytotherapic, and one of the most used plants is Bauhinia forficata.

Areas covered: In the current review, patents using Bauhinia forficata for the Diabetes Mellitus treatment have been analyzed. There were 03 patents in WIPO, 01 in Espacenet, 01 in USPTO, and 02 in INPI.

Expert opinion: Patents on the adjuvant treatment of Diabetes Mellitus by Bauhinia forficata are discussed. Although there are some phytotherapy products containing this medicinal plant which has hypoglycemic effect here is still a need for the development of more products based on natural resources, for the treatment of this pathology, without side effects and with other benefits, to assist in the glycemia control in diabetic patients, and to improve their quality of life.

Keywords:Bauhinia forficata  diabetes mellitus  phytotherapy  Flavonoids  kaempferol  insulin resistance
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号